Risks of antibacterial agents in pregnancy;Rischi dei farmaci antibatterici in gravidanza

Infezioni in Medicina

Volumn 10, Issue 1, 2002, Pages 8-15

  Nardiello, Salvatore ^a   Pizzella, Teresa ^a   Ariviello, Rosanna ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Antimicrobial agents; Bacterial infections; Pregnancy; Teratogenicity

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN DERIVATIVE; ERYTHROMYCIN ESTOLATE; ETHAMBUTOL; ISONIAZID; KETOLIDE; MACROLIDE; METRONIDAZOLE; NITROFURANTOIN; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; STREPTOGRAMIN DERIVATIVE; TETRACYCLINE DERIVATIVE; VANCOMYCIN;

ANTIMICROBIAL THERAPY; BACTERIAL INFECTION; CHEMICAL TERATOGENESIS; DRUG SAFETY; FETUS DEVELOPMENT; HUMAN; PREGNANCY; PREGNANCY COMPLICATION; REVIEW; RISK BENEFIT ANALYSIS; RISK FACTOR; SIDE EFFECT; TREATMENT PLANNING; TUBERCULOSIS;

ANTI-BACTERIAL AGENTS; FEMALE; HUMANS; PREGNANCY; RISK;

EID: 0036226020     PISSN: 11249390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (49)

1. Detection, significance, and therapy of bacteriuria in pregnancy
2. Antibiotics during pregnancy
3. Risk classification systems for drug use during pregnancy: Are they a reliable source of information?
4. Pharmacokinetics and safety of antimicrobial agents during pregnancy
5. A population-based case-control teratologic study of ampicillin treatment during pregnancy
6. Ticarcillin
7. In utero and in vitro exposure to beta-lactams impair kidney development in the rat
8. Augmentin treatment during pregnancy and the prevalence of congenital abnormalities: A population-based case-control teratologic study
9. Antibiotics in pregnancy
10. Assessment of infant development during an 18-month follow-up after treatment of infections in pregnant women with cefuroxime axetil
11. First trimester exposure to cefuroxime: A prospective cohort study
12. Use of cephalosporins during pregnancy and in the presence of congenital abnormalities: A population-based, case-control study
13. A population-based case-control teratologic study of oral erythromycin treatment during pregnancy
14. Maternal and infant use of erythromycin and other macrolide antibiotics as risk factors for infantile hypertrophic pyloric stenosis
15. Hepatotoxicity of erythromycin estolate during pregnancy
16. Fetal safety of nitrofurantoin macrocrystals therapy during pregnancy: A retrospective analysis
17. Pyelonephritis in pregnancy: A prospective randomised trial to prevent recurrent disease: Evaluating suppressive therapy with nitrofurantoin and close surveillance
18. Nitrofurantoin and congenital abnormalities
19. Teratology of the antitubercolosis drugs
20. Antitubercolous drugs
21. Ototoxicity of aminoglycoside antibiotics in infants and children
22. Quinolone antibacterials: An update of their pharmacology and therapeutic use
23. Safety of the new quinolones in pregnancy
24. Pregnancy outcome following gestational exposure to fluoroquinolones: A multicenter prospective controlled study
25. Birth outcome following maternal use of fluoroquinolones
26. Macrolides and clindamycin
27. Postmarketing surveillance of medications and pregnancy outcomes: Clarithromycin and birth malformations
28. A prospective controlled multicentre study of clarithromycin in pregnancy
29. Clinical pharmacokinetics of metronidazole and other nitro-imidazole anti-infectives
30. Metronidazole in pregnancy
31. Metronidazole use in obstetrics and gynecology: A review
32. Safety of metronidazole in pregnancy: A meta-analysis
33. Is metronidazole teratogenic? A meta-analysis
34. A population-based case-control teratologic study of oral metronidazole treatment during pregnancy
35. Pregnancy outcome after gestational exposure to metronidazole: A prospective controlled cohort study
36. Prenatal exposure to metronidazole and risk of childood cancer: A retrospective cohort study of children younger than 5 years
37. Embryolethality induced by metronidazole (MTZ) in Rattus norvegicus
38. Mycobacterium tuberculosis
39. Vancomycin during pregnancy: Does it cause hearing loss or nephrotoxicity in the infant?
40. Tetracycline toxicity in pregnancy: Liver and pancreatic dysfunction
41. Growth inhibition of prematures receiving tetracicline: Clinical and laboratory investigation
42. A population-based case-control teratologic study of oral oxytetracycline treatment during pregnancy
43. Antibiotics in pregnancy: Toxicity and teratogenicity
44. Teratogenic study of doxycycline
45. The teratogenic risk of trimethoprim-sulfonamides: A population-based case-control study
46. Teratogenesis and other adverse effects on the fetus of antimicrobial drugs used in pregnancy
47. A population-based case-control teratologic study of oral chloramphenicol treatment during pregnancy
48. The "grey toddler": Chloramphenicol toxicity